Talawar Therapeutics to go public via SPAC deal with $225M PIPE Jun 29, 2026 07:02AM
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics f Jun 29, 2026 07:00AM